Jim Mellon is a British entrepreneur, investor and philanthropist with a broad range of financial interests. Through the company he founded in 1994, the Burnbrae Group, Jim has a diverse portfolio of investments in private and public companies, as well as significant real estate holdings in Germany and the Isle of Man.
Jim’s core investment principles and beliefs are the result of meticulous research and analysis of nascent industries or extensive changes in markets. He has frequently predicted emerging market trends and identified global industry developments at an early stage. In his book ‘Wake Up!’ he famously foresaw the financial crash of 2008.
His 2017 book ‘Juvenescence' sparked a rush of capital into the expanding field of aging research, resulting in the formation of Juvenescence, a cutting-edge biopharmaceutical business focused on the commercialisation of therapies to delay, stop, and reverse aging.
Most recently, Jim wrote ‘Moo’s Law’, a book that focuses on investment opportunities in cellular agriculture and the new agrarian revolution. Jim co-founded Agronomics...Jim Mellon is a British entrepreneur, investor and philanthropist with a broad range of financial interests. Through the company he founded in 1994, the Burnbrae Group, Jim has a diverse portfolio of investments in private and public companies, as well as significant real estate holdings in Germany and the Isle of Man.
Jim’s core investment principles and beliefs are the result of meticulous research and analysis of nascent industries or extensive changes in markets. He has frequently predicted emerging market trends and identified global industry developments at an early stage. In his book ‘Wake Up!’ he famously foresaw the financial crash of 2008.
His 2017 book ‘Juvenescence' sparked a rush of capital into the expanding field of aging research, resulting in the formation of Juvenescence, a cutting-edge biopharmaceutical business focused on the commercialisation of therapies to delay, stop, and reverse aging.
Most recently, Jim wrote ‘Moo’s Law’, a book that focuses on investment opportunities in cellular agriculture and the new agrarian revolution. Jim co-founded Agronomics Ltd. in order to invest in companies leading the way in this sphere, and is its largest investor.
Jim is a member of the Board of Trustees of the American Federation for Aging Research (AFAR), the Buck Institute for Research on Aging and the Biogerontology Research Foundation. He is an Honorary Fellow of Oxford University's Oriel College, where he has founded the Mellon Centre for Longevity. Jim also sits on the Advisory Board of the Center for the Future of Aging, part of the Milken Institute.moreless
Jim Mellon, Co-Founder and Executive Director of Agronomics, spoke to Bloomberg about developments in alternatives to animal proteins, and his predictions for the food production industry.
The Burnbrae Group is a global investment company headquartered on the Isle of Man and focused on identifiable emerging trends. The company invests in the financial services, information technology, leisure, property, life sciences and mining sectors.
Juvenescence is a biotech company that has brought together a coalition of the best and most experienced scientists, drug developers, physicians, and investors to create cutting-edge therapies and products to improve the way we age. The company works closely with researchers worldwide and aims to empower people to plan their life journey and live longer.
Charlemagne Capital was founded by Jim in 2000 and was a venture capital business that specialised in the management of emerging market assets for clients. The business was acquired by Fiera Capital in 2018.
Regent Pacific is an investment company that focuses on growth and value‐led investments in the healthcare sector as well as in late‐stage life sciences industries.
SalvaRx Group is a pharmaceutical development company. Their focus is the development of effective pharmaceuticals for oncology patients. The company was previously known as 3legs Resources PLC.
Charlemagne Capital was acquired by Fiera Capital in 2018. Jim also serves as Board member at Charlemagne Capital UK Ltd and Charlemagne Capital Iom Ltd.
The Buck Institute for Research on Aging is the world’s first firm devoted solely to research on aging. The company is committed to helping people live better, longer.
Condor Gold Plc
Non-Executive Director
Jul 2012 - Present
London, UK
Condor Gold is a mineral exploration company that focuses on gold exploration and development in Nicaragua, Central America. The company was admitted to the LSE and AIM Market in 2006 and has been listed on the TSX since 2018. Jim also serves on the Board of Condor Resources PLC.
Manx Financial Group PLC is a holding company based on the Isle of Man with subsidiaries that offer a range of financial services, including retail and commercial banking services, payment and money saving solutions, foreign exchange, wealth management and insurance.
Speymill Deutsche Immobilien Co PLC was a real estate investment trust later acquired by Cerberus Capital Management. Jim also sits on the board of Speymill PLC.
Advisory Board Member, Center for the Future of Aging
Santa Monica, CA, USA
The Milken Institute is a non-profit global organization that supports people to build meaningful and healthy lives, in which they can access effective education and gainful employment whilst developing and contributing to their broader communities.
AgeX Therapeutics is a biotechnology company focused on the development of innovative medicines and the commercialization of newly emerging therapeutics targeting human aging.
Agronomics Limited is investment vehicle taking stakes in companies pioneering alternatives to meat and fish. The idea is to grow meat cleanly from cells and to avoid all the environmental and animal welfare consequences of traditional meat production.
Bradda Head Holdings Ltd., formerly Life Science Developments, is a lithium exploration company based in Douglas, Isle of Man. Bradda Head focuses on Identifying and developing quality lithium assets.
Rivington Street Holdings PLC
Board member
London, UK
Rivington Street Holdings PLC is a financial and media services company.
Portage Biotech (NASDAQ: PRTG) is a clinical-stage immuno-oncology company dedicated to revolutionising research into cancer and the development of world-leading treatments that contribute significantly in helping cancer patients improve their quality of life.
In 2021 The Longevity Forum took place in Glasgow during the COP26 climate summit. This panel session on the future of food and agriculture was moderated by the forum’s co-founder Jim Mellon and included Cassandra Coburn, Editor in Chief The Lancet; Henry Dimbleby Co-founder Leon Restaurants; and Eugene Klerk Head of Global ESG Credit Suisse.
In this podcast, Jim talks to Trey Lockerbie about his new book, "Moo's Law" and the conversation expands into the possibilities of human longevity, sustainable energy and related investments.
Jim is interviewed by Adam Ford of Science, Technology and the Future at the 2019 Undoing Aging Conference in Berlin. He discusses the increase in investment in biotech medicine and longevity.
Gene Munster interviews Jim for Loup TV. The pair discuss the possibility of longer life expectancy for human beings and maintaining quality of life as we age.
Interviewed by Samantha Somerset Webb for MoneyWeek, Jim talks about his future investment themes, the environment and recommends where Britons should be investing their money.
Jim has written Moo’s Law to help readers understand the landscape of investment in cultivated or plant-based proteins. He anticipates that global agriculture will be completely transformed by the growth of the cultivated meat technology industry over the next twenty years.
In this book, co-authors Jim Mellon and Al Chalabi present a roadmap to longevity, analysing the latest technologies available and describing how to benefit from them.
Authors Jim Mellon and Al Chalabi explore emerging disruptive technologies that offer good investment opportunities, spanning the fields of robotics, transportation, the changing internet, life sciences, 3D printing and energy.
Jim Mellon and Al Chalabi provide details of developing trends and innovations in the biotechnology sector. They also suggest how to profit from business ventures and investment in this industry.
Jim Mellon and Al Chalabi provide a step-by-step introduction to investments and provide practical advice to potential investors in real estate, stocks and mutual funds, bonds, BRIC economies, commodities and collectables, as well as green investments.
Simplifying the process of investment in this publication, Jim Mellon and Al Chalabi explore the best options available to investors over the next ten years.
Wake Up! explores the reasons for the unsustainable prosperity enjoyed by Western nations. The book provides an action plan to prosper in the coming economic downturn and guidance on surviving the expected collapse.
Formed in 2021, the Longevity Biotechnology Association brings together leaders in gerotherapeutics and geroscience with the aim of developing therapies and medicines to extend healthspan and end age-related diseases.
The American Federation for Aging Research has the provision of funding for biomedical research on aging at the heart of its mission. Jim was given the George E. and Marie J. Doty Award for his contribution to aging research.
Jim presents on the main stage at the 2019 Master Investor Show. He offers the audience his perspective on market developments and thematic economic trends.
